The neoplastic cells show an extremely high proliferation index with selleck inhibitor nearly 100% of tumor cells showing nuclear accentuation by Ki-67 (45). Molecular abnormalities As previously mentioned, all three subtypes of BL typically demonstrate any of three c-MYC translocations at band 8q24; the most common of which is with immunoglobulin heavy (IgH) chain gene at 14q32, and infrequently with Ig kappa (IgK) at 2p12 or Ig lambda (IgL) at 22q11. However, c-MYC rearrangement is not specific for BL. Approximately 28-50% of GI tract, de novo DLBCLs, and DLBCL, unclassifiable, with features intermediate Inhibitors,research,lifescience,medical between

DLBCL and BL (DLBCL/BL) show c-MYC translocation with a non-Ig gene partner, complex karyotype, and simultaneous BCL2, BCL6 and/or PAX5 translocations, referred to as “double or triple hit” lymphoma (43). Morphological overlap exists between BL and high-grade Inhibitors,research,lifescience,medical DLBCL and/or DLBCL/BL; therefore, it is imperative to differentiate BL from DLBCL

and DLBCL/BL, particularly since the latter two entities are more resistant to chemotherapy Inhibitors,research,lifescience,medical and carry a poorer prognosis overall (43). Prognosis BL is chemosensitive and the advent of high intensity, multi-agent chemotherapeutic regimen has led to an astoundingly high remission rate. As observed in one case, patients with concomitant H. pylori infection may also benefit from H. pylori eradication treatment (45). Epstein-Barr virus positive diffuse large B-cell lymphoma (EBV-positive DLBCL) of the elderly EBV-positive Inhibitors,research,lifescience,medical DLBCL is a clonal B-cell neoplasm in patients older than 50 years without known immunodeficiency or prior lymphoma (48,49). About 70% of these patients present with extranodal EBV-positive B-cell lymphomas in a number of locations, including the stomach in approximately 9% of cases (48). Pathogenesis EBV-positive DLBCL is believed to arise in the context of declining immunity related to senescence Inhibitors,research,lifescience,medical (48-50). As with

other variants of DLBCL, a clear etiology is not yet known. Morphology and immunophenotype Age-related EBV-positive lymphomas generally show large lymphoid cells in a background of smaller, reactive components (small lymphocytes, plasma cells, histiocytes, and epithelioid cells). There may also be patchy necrosis and a relatively broad range of B cell maturation, including morphologic centroblasts, immunoblasts, Anacetrapib and Hodgkin Reed Sternberg-like (HRS-like) giant cells with distinct nucleoli (49). This variability distinguishes the disease into two subtypes: large-cell and polymorphic. Large cell lymphoma is characterized by relatively monomorphic large lymphoid cells, while polymorphic lymphoma shows scattered large cells in a polymorphous background consisting of smaller lymphocytes, plasma cells, and histiocytes.